Application no. and date | 15733375.8 (espacenet) (Federated) (European Patent Register), 20150617 | Patent/reg. no. and date | DK/EP 3157629, 20221005 | Publication date | 20170426 | Priority no. and date | US 201462013157 P, 20140617 | EP pub. no. and date |
EP 3157629 20170426 | Effective date | | Applicant/owner | MedImmune Limited, Milstein Building Granta Park
Cambridge CB21 6GH, GB | Applicant ref. no. | 1529348 | Inventor | DOVEDI, Simon, University of Manchester Oxford Road
Manchester M13 9PL, GB, ILLIDGE, Tim, University of Manchester Oxford Road
Manchester M13 9PL, GB, STEWART, Ross, MedImmune Limited Milstein Building
Cambridge Cambridgeshire Granta Park, GB, MORROW, Michelle, MedImmune Limited Milstein Building
Cambridge Cambridgeshire Granta Park, GB, WILKINSON, Robert, MedImmune Limited Milstein Building
Cambridge Cambridgeshire Granta Park, GB, POON, Edmund, MedImmune Limited Milstein Building
Cambridge Cambridgeshire Granta Park, GB | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61N 5/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | FREMGANGSMÅDER TIL CANCERBEHANDLING MED ANTAGONISTER MOD PD-1 OG PD-L1 I KOMBINATION MED STRÅLEBEHANDLING | Int. application no. | EP2015063552 | Int. publication no. | WO2015193352 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|